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X-linked thrombocytopenia (XLT) is caused by mutations in the WAS gene and 
characterized by thrombocytopenia with minimal or no immunodeficiency. Patients with 
XLT usually exhibit persistent thrombocytopenia, and intermittent thrombocytopenia has 
been described only in two families. Here, we report a patient with intermittent XLT 
carrying a novel missense mutation (Ala56Thr). He showed residual expression of 
Wiskott-Aldrich syndrome protein in the lymphocytes and platelets. There appeared to be 
an association between normal platelet numbers and a post infectious state. Our findings 
further support the importance of analysis of Wiskott-Aldrich syndrome protein in male 





Wiskott-Aldrich syndrome protein (WASp) is an important regulator of the actin 
cytoskeleton and is constitutively expressed in all nonerythroid hematopoietic cells [1]. 
Mutations in the WAS gene result in either a loss or gain of protein function. The former 
leads to classical Wiskott-Aldrich syndrome (WAS) or isolated X-linked 
thrombocytopenia (XLT) [2,3], whereas the latter leads to a distinct disease, congenital 
X-linked neutropenia [4]. XLT is a milder phenotype of classical WAS that is 
characterized by persistent thrombocytopenia with minimal or no signs of eczema and 
immunodeficiency [1].  Notarangelo et al. reported 2 families in which affected males 
with unique amino acid substitutions in the WAS gene exhibited intermittent 
thrombocytopenia in the absence of other clinical features [5]. This rare condition is 
considered to be the mildest consequence of WASp deficiency. Herein, we report an 
additional case of intermittent XLT carrying a novel missense mutation. To further 
characterize the disease, the fluctuating course of thrombocytopenia, its relationship to 





The patient is a 4-year-old male whose medical history began shortly after birth 
with an abnormal newborn screening test for congenital hypothyroidism. His platelet 
counts were found to be in the normal range until 19 days of age, when he exhibited a late 
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rise in thyroid stimulating hormone (30.7 mIU/L) and began replacement therapy with 
levothyroxine. Thereafter, regular thyroid function testing offered us the opportunity to 
evaluate the complete blood count longitudinally, and mild thrombocytopenia was noted 
after one month of age (Figure 1A). He exhibited transient facial eczema during infancy. 
Ten days after he suffered from an influenza A infection at 8 months of age, the platelet 
count was elevated to 270 x 109/L. At 9 months of age, he was hospitalized for Norovirus 
gastroenteritis and marked thrombocytopenia (29 x 109/L). Platelet-associated 
immunoglobulin G was not elevated. Absolute neutrophil and lymphocyte counts were 
2.73 x 109/L and 5.38 x 109/L, respectively. Nine days later, his platelet count was 
elevated to 197 x 109/L. At 12 months of age, another episode of gastroenteritis due to 
Rotavirus occurred. The platelet number initially decreased to 12 x 109/L and, 5 days 
later, recovered to 205 x 109/L. Absolute neutrophil and lymphocyte counts at the initial 
time were 5.69 x 109/L and 0.97 x 109/L, respectively. A similar fluctuation in platelet 
counts was also observed after upper respiratory infection; however, infectious episodes 
did not necessarily result in normalization of platelet counts. No correlation was observed 
between platelet counts and thyroid hormones levels. The patient was found to have 
normal thyroid function, and levothyroxine treatment was discontinued at 3 years of age. 
Consistent with previous observations [5], the mean platelet volume (MPV) was 
persistently low, regardless of the platelet count (mean, 6.5 fL; Figure 1A).  
Immunological studies at 4 years of age revealed that proliferative response to 
immobilized anti-CD3 and podosome formation were detectable [6], albeit at lower levels 
than controls (Figure 1 B-C). The patient also exhibited a normal absolute lymphocyte 
count (4.76 x 109/L) and normal immunoglobulin (Ig) levels (IgG 9.23 g/L, IgA 1.74 g/L, 
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IgM 0.66 g/L). Immunophenotypic analysis of the lymphocytes showed normal or near-
normal percentage of CD3+ T (61.3%; normal, 71.4±5.8), CD4+ T (40.9%; normal, 
43.2±11.5), CD8+ T (14.1%; normal, 22.3±6.6), CD16+ NK (14.3%; normal, 6.3±3.9), 
and CD20+ B (19.9%; normal, 12.5±6.7) cells. Serum antibody titers to vaccinations were 
detected by enzyme immunoassay in the patient: measles-specific IgG 4.9 (normal, < 2.0) 
and rubella-specific IgG 3.1 (normal, < 2.0). Serum IgG antibody against 
cytomegalovirus was also positive: 4.9 (normal, < 2.0). Anti-A isohemagglutinin titer 
(IgM) was 1:64. The patient has shown no clinical evidence of immunodeficiency, 
autoimmunity or malignancy to date.  
As part of the clinical evaluation for thrombocytopenia, mutation analysis of the 
WAS gene was performed at 10 months of age, after informed consent was obtained from 
the parents. The patient had a G to A substitution at nucleotide 200 in exon 2, resulting in 
an Ala56Thr substitution (Figure 1D). While this missense mutation is novel, a similar 
missense mutation Ala56Val has been frequently reported in patients with XLT [7,8]. His 
mother was a heterozygous carrier of the mutation. We next analyzed WASp expression 
in peripheral blood mononuclear cells and platelets by flow cytometry and/or Western 
blot analysis (Figure 1 E-F) [9]. The lymphocytes, monocytes and platelets showed 







In this report, we described a case of intermittent XLT with a missense mutation 
(Ala56Thr) resulting in residual expression of the mutated WASp. These findings are in 
line with the previous description of intermittent XLT, in which the missense mutations, 
Pro58Arg and Ile481Asn, led to substantial protein expression in both lymphocytes and 
platelets [5]. Studies of platelets and lymphocytes from a series of patients with diverse 
WAS mutations, however, have demonstrated that platelets of most patients were shown 
to lack WASp, although a complex pattern of WASp expression was found in lymphoid 
cells [10,11]. Further studies will be necessary to assess whether residual WASp 
expression in platelets could be directly associated with intermittent thrombocytopenia. 
There appears to be an association between normal platelet numbers and a post 
infectious state in our patient. In healthy children, reactive thrombocytosis may occur 
following infections, in which significant elevation of thrombopoietin levels during an 
acute infection precedes the development of thrombocytosis [12]. Although we did not 
measure any growth factors related to megakaryopoiesis in our patient, the Ala56Thr 
missense mutation likely permitted the platelet elevation to occur following infections. 
Further investigations in intermittent XLT may lead to a better understanding of 
abnormalities in both platelet production and platelet consumption in WASp deficiency.  
It may be difficult to conclusively diagnose our patient as being affected with 
intermittent isolated XLT because of his young age. A scoring system on a scale of 1 to 5 
is used to estimate the severity of WAS/XLT-associated symptoms [13]. Progression 
from a low score representing XLT to the highest score of 5, due to either autoimmunity 
or malignancy, can occur at any age [8]. Despite the usefulness of the scoring system for 
assessment of the disease phenotype, it cannot predict the onset of autoimmunity or 
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malignancy. Indeed, malignancy has been reported in a patient with intermittent XLT 
carrying the Pro58Arg mutation [8]. Although hematopoietic stem cell transplantation is 
a treatment of choice for patients with classic WAS, there is a controversy in XLT due to 
the excellent long-term survival. However, if a human leukocyte antigen-identical donor 
is available, hematopoietic stem cell transplantation can be considered for patients with 
XLT because of their high probability of severe disease-related complications [8]. 
Therefore, careful follow-up is necessary for patients with WASp deficiency, including 
intermittent XLT. In addition, our findings further support the importance of analysis of 
WASp in male patients who present with fluctuating courses of thrombocytopenia, 
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Fig. 1.  Analysis of platelets and WASp.  
A: Profiles of the platelet counts and mean platelet volume (MPV). Shaded areas 
represent the ranges of normal values. B: Proliferative responses to anti-CD3. Data are 
presented of stimulation index (ratio between average incorporated [3H]thymidine in the 
presence of anti-CD3 to that in the absecence of stimulation). C: F-actin distribution in 
monocyte-derived dendritic cells. Visualization of F-actin was performed with Alexa 
Fluor 488-conjugated phalloidin. D: Mutational analysis of the WAS gene. Direct 
sequencing was performed using an automated sequencer. E: Flow cytometric analysis of 
WASp expression in lymphocytes and monocytes. White histograms indicate control 
antibody; gray histograms represent anti-WASp monoclonal antibody. F: Western blot 
analysis of WASp expression in B-cell lines and platelets. Arrows indicate the position of 
the WASp and of a non-specific reactive protein (NS). 
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Figure 1 
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